An abortion ban won’t happen all at once — mifepristone is just the next phase
Summary
A federal appeals court restricted access to mifepristone, a common abortion and miscarriage medication, by ending telehealth prescriptions. This decision is part of broader efforts to limit abortion access across the United States.Key Facts
- Mifepristone is widely used for abortion and miscarriage care in the U.S.
- A federal appeals court ruled to stop telehealth prescriptions of mifepristone.
- The restriction was not based on new safety concerns or evidence.
- This move is seen as part of a larger plan to limit abortion access nationwide.
- Telehealth allows patients to consult doctors remotely, which made access to mifepristone easier.
- The ruling affects how people can obtain this medication, potentially making it harder.
- The decision reflects ongoing legal battles over abortion rights in the U.S.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.